Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 418, 825-826 (22 August 2002) | doi:10.1038/418825a
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Group Leader Positions
- The International Iberian Nanotechnology Laboratory (INL)
- Braga Portugal
Carbohydrate Chemistry
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Medicine: Virus deals anthrax a killer blow
M. J. Rosovitz & Stephen H. Leppla
Abstract
The threat of antibiotic-resistant bacteria is driving researchers to think up ever more clever ways to tackle infections. An enzyme from a bacterium-killing virus may prove effective against anthrax infections.
Following the deliberate dissemination of spores of Bacillus anthracis, the bacterium that causes anthrax, through the US mail last autumn, public-health officials were faced with two major problems: detecting spores in buildings and on exposed individuals, and treating those people thought to be exposed and the few who actually became infected. Testing for spores required samples to be sent to specialized labs to be cultured, and took several days — a painfully long time when the public was insisting on immediate information and action.
- M. J. Rosovitz and Stephen H. Leppla are at the National Institute of Dental and Craniofacial Research, and will shortly be moving to the National Institute of Allergy and Infectious Diseases, Convent Drive MSC 4350, Bethesda, Maryland 20892-4350, USA.
Correspondence to: e-mail: Email: sleppla@mail.nih.gov
To read this story in full you will need to login or make a payment (see right).
